Hypersensitivity pneumonitis

Read full text Summarise with VIRAT
Authors: Dursun Duman
Cited by: 0
References: 34

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Hypersensitivity pneumonitisHypersensitivity pneumonitis (HP) is an immune-mediated interstitial lung disease that develops in susceptible individuals following exposure to identifiable or unidentified antigens.Traditionally, HP was classified into acute, subacute, and chronic forms.However, the 2020 ATS/JRS/ALAT guideline introduced a new dichotomous classification into non-fibrotic and fibrotic HP, emphasizing the presence or absence of fibrosis as the key determinant based on radiologic and histopathologic findings.The 2021 CHEST expert panel statement further refined the diagnostic algorithm by integrating exposure history, high-resolution computed tomography patterns, and bronchoalveolar lavage lymphocytosis into a probability-based diagnostic framework.Most recently, the 2025 German S2k guideline proposed an extended three-tiered system-acute, chronic nonfibrotic, and chronic fibrotic HP-and provided updated recommendations for diagnostic pathways and antifibrotictherapy.In light of these evolving perspectives, this review aims to comprehensively discuss the diagnostic and therapeutic strategies for HP, comparing and contrasting the approaches and key recommendations across majör international guidelines.

Fields of Study & Subjects

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Occupational and environmental lung diseases Transplantation: Methods and Outcomes

Publication details

Journal / source
Tuberkuloz ve Toraks
Volume
74
Issue
1
Pages
58–65
Publication date
25 March 2026
Language
EN